Sattva Sukun Lifecare Ltd promoter Roshan Dealmark Private Limited disposed of 14,00,000 equity shares through an on-market transaction on September 7, 2026. The sale reduces the promoter group’s aggregate stake in the company to 5.66%.

The disclosure was filed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. Roshan Dealmark is part of the promoter group acting in concert with Puja Agarwal.

Holding Changes

Before the transaction, Roshan Dealmark held 2,30,49,777 shares, while Puja Agarwal held 80,000 shares. The combined promoter group stake stood at 2,31,29,777 shares, representing 6.02% of the total diluted share capital.

Following the disposal, Roshan Dealmark’s holding decreased to 2,16,49,777 shares. Puja Agarwal’s stake remained unchanged at 80,000 shares. The total promoter group holding now stands at 2,17,29,777 shares.

The company’s paid-up equity capital remains unchanged at ₹38,36,01,248, comprising 383,601,248 shares of ₹1 each. The transaction was executed entirely through on-market trades on the Bombay Stock Exchange.

Tavexia Lifecare Limited board approved a proposal to acquire up to 60% equity share capital of Meyonex Pharmaceuticals Limited, an unlisted public company, during its meeting on September 7, 2026.

The board authorized directors Chirag Deepak Dedhia and Sachin Bhanubhai Manseta to lead preliminary evaluations, due diligence, and negotiations for the transaction. This move signals a strategic expansion into the pharmaceutical sector, targeting Meyonex, which has an authorized capital of ₹20 crore and paid-up capital of ₹13.99 crore.

Auditor and Board Changes

The company accepted the resignation of its statutory auditors, M/s SSRV & Associates, effective September 7, 2026. Consequently, the board approved the appointment of M/s DEVAM & Associates LLP as the new statutory auditors. This appointment is subject to shareholder approval at the upcoming Annual General Meeting (AGM) and covers a five-year term from FY27 to FY31.

Additionally, the board recommended the reappointment of Mrs. Khushboo Vasudev as an independent director for a second five-year term, starting December 31, 2026, pending shareholder approval.

Key Financials of Target Entity

Corporate Governance Updates

The board also approved the specific limit for material related-party transactions under Section 188 of the Companies Act, 2013, recommending it for shareholder approval. It took on record the secretarial audit report for FY25-26 from M/s Brajesh Gupta & Co. and approved the Board Report, Corporate Governance Report, and Management Discussion and Analysis for the financial year ended March 31, 2026.

The 46th AGM will be held with book closure dates fixed from September 24, 2026, to September 30, 2026. Mr. Brajesh Gupta was appointed as the scrutinizer for the e-voting process.